Connect with:
Thursday / December 26. 2024
HomeAgroPolicyGujarat govt organise pre-event of 10th Vibrant Gujarat Global Summit 2022

Gujarat govt organise pre-event of 10th Vibrant Gujarat Global Summit 2022

Image credit: PIB

A pre-event summit has been organised by the Health & Family Welfare Department, Government of Gujarat, with a theme “Holistic Healthcare focused on Pharmaceuticals and Medical Devices” on December 18, 2021

The Government of Gujarat is organising the 10th Vibrant Gujarat Global Summit 2022, from January 10 -12, 2022, at Mahatma Mandir Convention and Exhibition Centre, Gandhinagar, Gujarat. A pre-event summit has been organised by the Health & Family Welfare Department, Government of Gujarat, with a theme “Holistic Healthcare focused on Pharmaceuticals and Medical Devices” on December 18, 2021, in Pandit Deendayal Energy University, Gandhinagar, Gujarat.

The pre-event summit was inaugurated by Mansukh Mandaviya, Union Minister for Health & Family Welfare and Chemicals & Fertilisers and Bhupendra Patel, Chief Minister of Gujarat. S Aparna, IAS, Secretary, Department of Pharmaceuticals, Government of India, Dr Sarah Mcmullen, India Office Country Director, United States Food and Drug Control Administration (US FDA) and Dr V G Somani, Drugs Controller General of India were also present on the occasion.

The pre-event summit focused on the following:

  • Boosting Bulk Drug Production through Production Linked Incentive (PLI) Scheme
  • Reducing India’s Dependence in Active Pharmaceutical Ingredients (APIs) & Medical Devices
  • Jan Aushadhi Kendras – Generic Medicines

During the summit, Mansukh Mandaviya, inaugurated the stall of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) Through the PMBJP stall, PMBI informed the salient features of PMBJP and benefits of Jan Aushadhi Generic Medicines which are available at affordable prices through more than 8500 Pradhan Mantri Bhartiya Janaushadhi Kendras, functioning across the country.

During this pre-event summit, technical sessions covered various aspects of the Production Linked Incentive (PLI) Scheme and the opportunities to enhance bulk drug production.

No comments

leave a comment